Literature DB >> 16695341

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). IV. PHARMACOLOGIC OBSERVATIONS ON BAL BY INTRAMUSCULAR INJECTION IN MAN.

W Modell1, H Gold, M Cattell.   

Abstract

Entities:  

Year:  1946        PMID: 16695341      PMCID: PMC435587          DOI: 10.1172/JCI101731

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  2 in total

1.  BAL (BRITISH ANTI-LEWISITE).

Authors:  L L Waters; C Stock
Journal:  Science       Date:  1945-12-14       Impact factor: 47.728

2.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION.

Authors:  M B Sulzberger; R L Baer; A Kanof
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

  2 in total
  8 in total

1.  Gold dermatitis, treated with B.A.L.; toxic manifestations; related (?) to calcium deprivation.

Authors:  B GREEN; B F RUSSELL
Journal:  Proc R Soc Med       Date:  1948-02

2.  Bal in the Treatment of Gold Toxicity.

Authors:  J G Macleod
Journal:  Ann Rheum Dis       Date:  1948       Impact factor: 19.103

3.  British anti-lewisite; a report on its use and therapeutic value in arsenical intoxications, from the BAL Conference, Medical Research Council.

Authors:  R A PETERS; J BENNET
Journal:  Br Med J       Date:  1947-10-04

4.  The effects of 2.3-dimercaptopropanol (BAL) on gold reactions.

Authors:  G EDSTROM
Journal:  Ann Rheum Dis       Date:  1950-06       Impact factor: 19.103

5.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). XI. THE TREATMENT OF ACUTE MERCURY POISONING BY BAL.

Authors:  W T Longcope; J A Luetscher; E Calkins; D Grob; S W Bush; H Eisenberg
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

6.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION.

Authors:  M B Sulzberger; R L Baer; A Kanof
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

7.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL.

Authors:  W T Longcope; J A Luetscher; M M Wintrobe; V Jäger
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

Review 8.  Metals and Metal-Nanoparticles in Human Pathologies: From Exposure to Therapy.

Authors:  Joanna Izabela Lachowicz; Luigi Isaia Lecca; Federico Meloni; Marcello Campagna
Journal:  Molecules       Date:  2021-11-02       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.